Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -52.46 | N/A |
| PEG Ratio (TTM) | -2.71 | N/A |
| P/S Ratio (TTM) | 0.90 | N/A |
| P/B Ratio (TTM) | 1.14 | N/A |
| P/FCF Ratio (TTM) | 2.21 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.94 | N/A |
| Price to 5YR AVG FCF Ratio | 2.50 | N/A |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.16% | N/A |
| ROE (TTM) | -1.96% | N/A |
| Net Profit Margin (TTM) | -1.72% | N/A |
| ROIC 5YR AVG | 5.65% | N/A |
Growth (93%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.80% | 101.71% | 36.31% |
| Revenue | 4.62% | 17.12% | 7.29% |
| Net Income | 13.52% | 100.60% | 35.88% |
| Cash Flow | 32.60% | 122.96% | 68.62% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.13 | N/A |
| Quick Ratio (TTM) | 1.01 | N/A |
| D/E Ratio (TTM) | 0.58 | N/A |
| Interest Coverage (TTM) | 0.55 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 1.61 | N/A |
| LTL to 5YR AVG FCF | 1.12 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.49% | N/A |